ArticleLeukemia2021

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia.

Bruno Paiva et al.PubMed ↗Publisher ↗

No numbers read from the abstract.